Effects of traditional Chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis

Inflammation

Volumn 31, Issue 2, 2008, Pages 121-132

  Gao, Yuan ^a   Song, Lin Xuan ^b   Jiang, Miao Na ^a   Ge, Guang Yan ^c   Jia, Yu Jie ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Dalian Second People's Hospital   (China)

^c Third People's Hospital of Dalian   (China)

Author keywords

CD14; Lipopolysaccharide; Nonalcoholic steatohepatitis; Rat; Toll like receptor 4

Indexed keywords

ALANINE AMINOTRANSFERASE; ATORVASTATIN; CD14 ANTIGEN; CHINESE DRUG; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE BINDING PROTEIN; MYELOID DIFFERENTIATION 2; REGULATOR PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; MICROSCOPY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE-PHASE PROTEINS; ALANINE TRANSAMINASE; ANIMALS; ANTIGENS, CD14; CARRIER PROTEINS; DIETARY FATS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; ENDOTOXINS; FATTY LIVER; HEPATITIS; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; LIPIDS; LIVER; LYMPHOCYTE ANTIGEN 96; MALE; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; POLYMERASE CHAIN REACTION; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 45449103635     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-008-9057-3     Document Type: Article

References (36)

1. Matteoni, C. A., Z. M. Younossi, T. Gramlich, N. Boparai, Y. C. Liu, and A. J. McCullough. 1999. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116(6):1413-1419.
2. Ratziu, V., P. Giral, F. Charlotte, E. Bruckert, V. Thibault, I. Theodorou, et al. 2000. Liver fibrosis in overweight patients. Gastroenterology 118(6):1117-1123.
3. Powell, E. E., W. G. Cooksley, R. Hanson, J. Searle, J. W. Halliday, and L. W. Powell. 2004. The natural history of nonalcoholic steatohepatiti: a follow-up study of forty-two patients for up to 21 years. J. Hepatol. 40(4):578-584.
4. Marchesini, G., M. Brizi, G. Bianchi, et al. 2001. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50(8):1844-1850.
5. Sanyal, A. J., C. Campbell-sargent, F. Mirshahi, et al. 2001. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gasteroenterology 120(5):1183-1192.
6. Laskin, D. L., B. Weinverger, and J. D. Laskin. 2001. Functional heterogeneity of liver and lung macrophage. J. Leukoc. J. Leukoc. Biol. 70:163.
7. Portincasa, P., L. Grattagliano, V. O. Palmieri, and G. Palasciano. 2005. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin. Clin. Biol. 38:203-217.
8. Wigg, A. J., I. C. Roberts-Thomson, R. B. Dymock, P. J. McCarthy, R. H. Grose, and A. G. Cummins. 2001. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxemia, and tumor necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis. Gut 48:206-211.
9. Lichtman, S. N., J. Keku, J. H. Schwab, and R. B. Sartor. 1991. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 100(2):513-519.
10. Xu, Z.-J., J.-G. Fan, G.-L. Wang, X.-D. Ding, L.-Y. Tian, and X.-Y. Zheng. 2003. The effect of lactulose on the establishment of a rat model of non-alcoholic steatohepatitis. Zhonghua Xiaohua Zazhi. 23:97-100.
11. Zou, G.-Q., S. He, C.-A. Liu, and J.-P. Gong. 2002. Expression of lipopolysaccaride receptor CD14 in experimental alcoholic liver disease. Chin. J. Hepatol. 10(3):207-210.
12. Qiao, A.-Y., Y.-D. Qian, X. Yang, and J.-S. Li. 2005. Implication of TLR4 and CD14 mRNA expression in lung and hepatic tissues in sepsis rats. Chin. J. Exp. Surg. 22(8):952-953.
13. Du, X.-H., Y.-M. Yao, R. Li, C.-A. Shen, and H.-N. Yin. 2005. Effects of toll-like receptor 4 and MD-2 gene expression in the lungs in septic rats on sex differences. Chin. Crit. Care MED. 12(17):726-728.
14. Liu, H., Z. Ma, and S. S. Lee. 2000. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology 118:937-934.
15. Tilg, H., and A. Diehl. 2000. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343:1467-1476.
16. Romics, L., Jr., K. Kodys, A. Dolganiuc, L. Graham, A. Velayudham, P. Mandrekar, et al. 2004. Diverse regulation of NF-κB and peroxisome proliferator-activated receptors in nonalcoholic fatty liver. Hepatology 40:376-385.
17. Yang, S. Q., H. Z. Lin, M. D. Lane, M. Clemens, and A. M. Diehl. 1997. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Proc. Natl. Acad. Sci. U.S.A. 94:2557-2562.
18. Wu, R. Q., Y. X. Xu, X. H. Song, L. J. Chen, and X. J. Meng. 2001. Adhesion molecule and proinflammatory cytokine gene expression in hepatic sinusoidal endothelial cells following cecal ligation and puncture. World J. Grastroenterol. 7:128-130.
19. Gutsmann, T., M. Muller, S. F. Carroll, R. C. Mackenzie, A. Wiese, and U. Seydel. 2001. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect. Immun. 69:6942-6950.
20. Heumann, D., Y. Adachi, D. Le Roy, N. Ohno, T. Yadomae, M. P. Glauser, et al. 2001. Role of plasma, lipopolysaccharide-binding protein, and CD14 in response of mouse peritoneal exudates macrophages to endotoxin. Infect. Immun. 69:378-385.
21. Tobias, P. S., K. Soldau, J. A. Gegner, D. Mintz, and R. J. Ulevitch. 1995. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270(18):10482-101488.
22. da Silva, C. J., K. Soldau, U. Christen, P. S. Tobias, and R. J. Ulevitch. 2001. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276:21129-21135.
23. Lemaine, B., E. Nicolas, L. Micham, J. M. Reichhan, and J. A. Hoffmann. 1996. The dorsovemtrad regulatory gene casseue spaizle/Toll/cacuis controls the potent antifungal response in Drosophila adults. Cell 86:973-983.
24. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U.S.A. 95:588-593.
25. Romics, L. J., P. Mandrekar, K. Kodys, A. Velayudham, Y. Drechsler, A. Dolganiuc, et al. 2005. Increased lipopolysaccharide sensitivity in alcoholic fatty livers is independent of leptin deficiency and toll-like receptor 4 (TLR4) or TLR2 mRNA expression. Res. Soc. Alcohol 29(6):1018-1026.
26. Yong-Han, P., F. S. Robert, B. Ramon, P. R. Maria, J. Christian, and A. B. David. 2003. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37:1043-1055.
27. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, et al. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189(11):1777-1782.
28. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14. a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249(4975):1431-1433.
29. Medvedev, A. E., and S. N. Vogel. 2003. Overexpression of CD14, TLR4, and MD-2 in HEK 293T cells does not prevent induction of in vitro endotoxin tolerance. J. Endotoxin. Res. 9:60-64.
30. Akashi, S., S. Saitoh, Y. Wakabayashi, T. Kikuchi, N. Takamura, Y. Nagai, et al. 2003. Lipopolysaccharide interaction with cell surface toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J. Exp. Med. 198(7):1035-1042.
31. Schroder, N. W., S. Morath, C. Alexander, L. Hamann, T. Hartung, U. Zahringer, et al. 2003. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278:15587-15594.
32. Baldwin, A. S. Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
33. Tazi, K. A., J. J. Quioc, V. Saada, A. Bezeaud, D. Lebrec, and R. Moreau. 2006. Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M. Hepatology 45:280-289.
34. Kim, Y. M., B. S. Lee, K. Y. Yi, and S. G. Paik. 1997. Upstream NF-κB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-γ plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 236:655-660.
35. Dejkhamron, P., J. Thimmarayappa, K. Kotlyarevska, J. Sun, C. Lu, E. L. Bonkowski, et al. 2007. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways. Mol. Cell Endocrinol. 274:35-42.
36. Song, M. J., K. H. Kim, J. M. Yoon, J. B. Kim. 2006. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem. Biophys. Res. Commun. 346:739-745.